0001477932-26-004958 Sample Contracts
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 13th, 2026 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 5, 2026, by and between Guided Therapeutics, Inc., a Delaware corporation, with headquarters located at 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA 30092 (the “Company”), and LABRYS FUND II, L.P., a Delaware limited partnership, with its address at 145 Tremont Street, Suite 201-1408, Boston, MA 02111 (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 13th, 2026 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus • Virginia
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 25, 2026, by and between GUIDED THERAPEUTICS, INC., a Delaware corporation, with its address at 5835 Peachtree Corners East, Suite B, Peachtree Corners, Georgia 30092 (the “Company”), and Vanquish Funding Group Inc., a Virginia corporation, with its address at 1800 Diagonal Road, Suite 623, Alexandria VA 22314 (the “Lender”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 13th, 2026 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus • Nevada
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 5, 2026, by and between GUIDED THERAPEUTICS, INC., a Delaware corporation, with headquarters located at 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA 30092 (the “Company”) and GS CAPITAL PARTNERS, LLC, with its address at 1325 Airmotive Way, Suite 202, Reno, NV 89502 (the “Buyer”).
COMMON STOCK PURCHASE WARRANT GUIDED THERAPEUTICS, INC.Common Stock Purchase Warrant • August 13th, 2026 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Mark L. Faupel or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after date hereof (the “Date of Issuance”) and on or prior to 5:00 p.m. (New York City time) on June 14, 2031 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Guided Therapeutics, Inc., a Delaware corporation (the “Company”), up to 2,000,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
MEMORANDUM OF UNDERSTANDING CONFIDENTIAL JUNE 30, 2026Memorandum of Understanding • August 13th, 2026 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus
WHEREAS Guided Therapeutics, Inc, a Georgia. United States of American corporation ("GTI") located at 5835 Peachtree Comers East, Suite D. Peachtree Comers, Georgia 30092 ("GTI") and Jiangsu Yuanshuo Medical Instruments Corporation. The 3rd Floor, No. 12, North Area of High-end Equipment Manufacturing Industrial Park, Ring North Road, Jiangsu Pizhou Economic Development Zone, Pizhou City, Xuzhou City, Jiangsu Province Peoples Republic of China ("YMIC") (GTI and YMIC collectively referred to herein as "Parties" or individually as "Party") on 9 November 2025 entered into an agreement to together to help commercialize in China GTI’s first non-invasive cancer detection product, the LuViva ® Advanced Cervical Scan device (the "Device") and the related disposable cervical guides (the "Cervical Guides" and, with the Device, "Lu Viva" aka in China as “Zealight”.